DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

ExpertiseUpdated on 28 April 2026

Nanobody engineering and translational biologics development

Nicolás Galmarini

CEO & Co-founder at NanoVet Biotech

Pamplona, Spain

About

NanoVet brings deep expertise in nanobody engineering and translational biologics development, integrating target biology, molecular design, and developability considerations to create efficient and scalable therapeutic solutions. Our team combines scientific and commercial experience to bridge early discovery with real-world application, with a particular focus on delivering cost-effective biologics for veterinary markets where traditional antibody approaches are often limited.

Similar opportunities